SISTEMA INTEGRAL DE INFORMACIÓN ACADÉMICA - PÚBLICO

Mejia-Vilet J.M.
(Autor externo)

Obras con ISBN:0
Documentos en revistas:27
Colaboraciones en Tesis:0
Patentes:0
Obras con ISBN:No hay obras de este autor.
Documentos en revistas:
1.- Steroid-induced diabetes in lupus nephritis patients: Classic risk factors or a different type of diabetes? (2025)
 
2.- Down-Regulation?Resistant STAT4 Risk Haplotype Contributes to Lupus Nephritis Through CD4+ T Cell Interferon-? Production (2023)
 
3.- Urinary serpin-A3 is an early predictor of clinical response to therapy in patients with proliferative lupus nephritis (2022)
 
4.- ANCA-associated vasculitis and IgG4-related disease overlap syndrome: a case report and literature review (2022)
 
5.- Urinary Serpin-A3 is an Early Predictor of Clinical Response to Therapy in Patients with Proliferative Lupus Nephritis (2022)
 
6.- New-onset systemic lupus erythematosus beginning as class V lupus nephritis after COVID-19 vaccination (2021)
 
7.- Community- And Hospital-Acquired Acute Kidney Injury in COVID-19: Different Phenotypes and Dismal Prognosis (2021)
 
8.- Association Between Urinary Epidermal Growth Factor and Renal Prognosis in Lupus Nephritis (2021)
 
9.- Prolonged Intermittent Renal Replacement Therapy for Acute Kidney Injury in COVID-19 Patients with Acute Respiratory Distress Syndrome (2021)
 
10.- Alternative complement pathway activation in thrombotic microangiopathy associated with lupus nephritis (2021)
 
11.- High frequency of nocturnal hypertension in lupus nephritis: should ABPM be implemented in usual practice? (2020)
 
12.- Angiotensin II receptor agonist antibodies are associated with microvascular damage in lupus nephritis (2020)
 
13.- A risk score to predict admission to the intensive care unit in patients with Covid-19: the ABC-GOALS score (2020)
 
14.- Urinary soluble CD163: A novel noninvasive biomarker of activity for lupus nephritis (2020)
 
15.- Nephrotic syndrome in the setting of LECT2 amyloidosis: Take a look at the podocyte (2020)
 
16.- Anasarca in a Patient With Polyneuropathy (2019)
 
17.- Immune gene expression in kidney biopsies of lupus nephritis patients at diagnosis and at renal flare (2019)
 
18.- LECT2 Amyloidosis in Kidney Transplantation: A Report of 5 Cases (2019)
 
19.- Calcineurin Inhibitors With Reduced-Dose Steroids as First-Line Therapy for Focal Segmental Glomerulosclerosis (2019)
 
20.- Simple risk score for prediction of haemorrhagic complications after a percutaneous renal biopsy (2018)
 
21.- Prognostic significance of renal vascular pathology in lupus nephritis (2017)
 
22.- Renal flare prediction and prognosis in lupus nephritis Hispanic patients (2016)
 
23.- Clinical presentation and outcome prediction of clinical, serological, and histopathological classification schemes in ANCA-associated vasculitis with renal involvement (2016)
 
24.- Facing the metabolic syndrome epidemic in living kidney donor programs (2016)
 
25.- Comparison of lupus nephritis induction treatments in a hispanic population: A single-center cohort analysis (2015)
 
26.- Renal ischemia-reperfusion injury is prevented by the mineralocorticoid receptor blocker spironolactone (2007)
 
27.- Comment on ?Clinical Practice Guidelines for the Treatment of Systemic Lupus Erythematosus by the Mexican College of Rheumatology? ()
 
Colaboraciones en Tesis:No hay tesis de este autor.
Patentes:No hay patentes de este autor.